No Picture
News

Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter

LAGUNA HILLS, Calif., Aug. 3, 2020 /PRNewswire/ — Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

MVPvets Appoints New Board Member and Launches The Academy, Providing Veterans with Virtual Training, Mentorship, and Access to The MedTech Conference

SAN DIEGO, July 28, 2020 /PRNewswire/ — MVPvets, a 501(c)(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in medical device and life science companies, announced the appointment of board… […]

No Picture
News

ImpediMed and The US Oncology Network Sign Agreement for Major Roll-Out of SOZO® Technology as Part of Lymphedema Prevention Program

SOZO Devices to Power Network’s Initiative to Prevent Lymphedema in Cancer Patients

CARLSBAD, Calif., June 29, 2020 /PRNewswire/ — ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid sta… […]

No Picture
News

Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020

SAN DIEGO, June 16, 2020 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has developed a proprietary bispecific antibody technology platform, PACbodyT… […]

No Picture
News

Qualigen Therapeutics Releases FastPack® SARS-CoV-2 Antibody Diagnostic Test to University of Louisville to Conduct Validation Studies

CARLSBAD, Calif., June 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed FastPack® SARS-CoV-2 IgG Immunoassay diagnostic tes… […]

No Picture
News

Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases

Multi-Target Collaboration Leverages Vividion’s Screening Platform to Discover and Develop Highly Selective Small Molecules for E3 Ligases and Select Oncology and Immunology TargetsVividion Receives $135 Million Upfront Payment With Potential for Multi… […]

No Picture
News

Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector(TM) BRAF Kit for Clients’ Use in Their Own Laboratories

Target Selector(TM) molecular assay kits are research-use-only (RUO) and offer superior sensitivity compared to NGS-based biomarker analysis for the detection of key actionable oncogene mutations

SAN DIEGO, May 14, 2020 /PRNewswire/ — Biocept, Inc. … […]

No Picture
News

Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples

SAN DIEGO, April 20, 2020 /PRNewswire/ –?Biocept, Inc. (NASDAQ: BIOC),?a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with … […]

No Picture
News

Brazil Patent Granted for Biocept’s Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform

Expands global intellectual property portfolio for highly sensitive methods of detecting cancer biomarkers in circulating tumor DNA (ctDNA) and other genetic alterations of interest; increases Biocept’s total patent awards for technologies used in mole… […]

No Picture
News

Mesa Biotech To Ship 10,000 Accula SARS-CoV-2 Tests This Week For 30 Minute Rapid Molecular Point of Care Diagnosis

The only FDA authorized palm-sized system for COVID-19 testing enables broader use across healthcare facilities and closer to the patients with rapid results

SAN DIEGO, April 7, 2020 /PRNewswire/ –?Today, Mesa Biotech announced it is shipping 10,000… […]